NVCR Q2 2022 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q2 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$141M+5.5% YoY

Gross Profit

$112M79.8% margin

Operating Income

-$21M-15.0% margin

Net Income

-$24M-17.0% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

+2.4%

Cash Flow

Operating Cash Flow

$16M

Free Cash Flow

$12M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$721M

Stockholders' Equity

$442M

Cash & Equivalents

$367M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$141M	$134M	+5.5%
Gross Profit	$112M	$105M	+7.1%
Operating Income	-$21M	-$12M	-71.8%
Net Income	-$24M	-$15M	-64.0%

Geographic Segments

UNITED STATES

$108M77%

GERMANY

$10M7%

JAPAN

$8M6%

EMEA, Exculding Germany

$8M6%

CHINA

$6M4%